Asia-Pacific Prazosin Market Size, Share, Impressive Industry Growth, Analysis Report 2028

 

Asia-Pacific Prazosin Market is estimated to decline during the forecast period. However, some factors are positively influencing market growth to some extent. According to the European Society of Cardiology (ESC) in 2018, a report presented by a team of scientists suggested that one in five young adults in India has high blood pressure, which equals to nearly 80 million adults. The major risk factors for high blood pressure in the region include smoking, tobacco chewing, diabetes mellitus, and high cholesterol. Further, prazosin finds application in the treatment of various other conditions such as BPH, congestive heart failure, pheochromocytoma (adrenal gland tumor), sleep problems associated with PTSD; an anxiety disorder in people who experience or witness a traumatic, life-threatening event. However, due to the availability of alternatives the market for prazosin is projected to decline in the region. 

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/asia-pacific-prazosin-market

Asia-Pacific Asia-Pacific Prazosin Market is segmented on the basis of application. Based on the application, the market is segmented into cardiovascular disease, neurological syndromes, prostate disorders, and kidney disorders. The CVD segment accounted for a significant share in the Asia-Pacific Asia-Pacific Prazosin Market. CVDs claim to take more lives each year than all forms of cancer and chronic lower respiratory diseases altogether. Thus, Prazosin is one of the treatments used for CVD mainly high BP and strokes. For instance, Minipress is specified for the treatment of hypertension, to control BP. Lowering blood pressure decreases the risk of fatal and nonfatal cardiovascular events, mainly strokes and myocardial infarction.  

The companies which are contributing to the growth of the Asia-Pacific Asia-Pacific Prazosin Market include Ajinomoto Co., Inc., Standard Chem and Pharmaceuticals Co. Ltd., Sun Pharmaceuticals Industries Ltd., Merck KGaA, Mylan N.V., Pfizer Inc., and others. The market players are considerably contributing to the market by adopting various strategies including new product launch, merger, and acquisition, collaborations to stay competitive in the market.

Asia-Pacific Prazosin Market- Segmentation

By Application

·         Cardiovascular Disease(CVD)

·         Neurological Syndromes 

·         Prostate Disorders

·         Kidney Disorders

A full report of Asia-Pacific Prazosin Market is available at: https://www.omrglobal.com/industry-reports/asia-pacific-prazosin-market

Asia-Pacific Prazosin Market– Segment by Region

·         China

·         India

·         Japan

·         Rest of Asia-Pacific

Company Profiles

·         Ajinomoto Co., Inc.

·         Johnlee Pharmaceuticals Pvt. Ltd.

·         Merck KGaA

·         Pfizer Inc.

·         R&D Systems Inc.

·         Renata Ltd.

·         Mylan N.V.

·         Standard Chem and Pharmaceuticals Co. Ltd.

·         Sun Pharmaceuticals Industries Ltd.

·         Teva Pharmaceuticals Industries Ltd.

Reasons to Buying From us –

1.       We cover more than 15 major industries, further segmented into more than 90 sectors.

2.       More than 120 countries are for analysis.

3.       Over 100+ paid data sources mined for investigation.

4.       Our expert research analysts answer all your questions before and after purchasing your report.

 

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

 

Media Contact:

Contact Person: Mr. Anurag Tiwari

Email: anurag@omrglobal.com

Contact no: +91 780-304-0404

Company Name: Orion Market Research